Biomedican
PrivateLast Round
Crowdfunding
Oct 1, 2021
Total Funding Raised
$3M
Company Overview
Biomedican is a biotechnology company that designs patented low-cost methods of growing high-value compounds, such as rare cannabinoids and astaxanthin, at scale using proprietary yeast fermentation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomedican Comparables
Compare Biomedican with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hyasynth Biologicals Inc. | 93% | |
| Creo | 88% | |
| Cellibre | 87% | |
Biomedican Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Oct 1, 2021 | ||||
| Early Funding | Oct 11, 2019 | ||||
| Early Funding | Jan 29, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 50% MoM.
- Jan 5, 2026
Monthly visitors grew 76% MoM.
Biomedican Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biomedican's valuation, stock price, and market status.